Stock Events

Stock Events

OncoSil Medical 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27AugExpected
Q4 2023
Next
-0.71
-0.37
-0.04
0.29
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,294.15%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
671,567.55Revenue
-8.69MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow N6A.STU. It's not an investment recommendation.
CSL
2
CSL.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Elekta AB
EKTAY
Mkt Cap2B
Elekta AB provides equipment and software for cancer treatment, including brachytherapy which is similar to OncoSil Medical's targeted radiation therapy.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical offers robotic surgical solutions, often used in the treatment of cancers, competing with OncoSil's approach in terms of offering minimally invasive options.
Baxter International
BAX
Mkt Cap11.68B
Baxter International produces medical devices and pharmaceuticals that are used in the treatment of various cancers, overlapping with OncoSil Medical's market.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation develops medical devices that are used in various interventional medical specialties, including oncology.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc provides medical technologies, services, and solutions, including cancer treatments that compete with OncoSil Medical's offerings.
Sensus Healthcare
SRTS
Mkt Cap50.21M
Sensus Healthcare focuses on non-invasive treatments of non-melanoma skin cancers and keloids with superficial radiation therapy, competing in the radiation therapy space.
Accuray
ARAY
Mkt Cap28.71M
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for alternative cancer treatments.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. provides healthcare solutions that, while primarily focused on orthopedics, also offers products that can be used in surgical oncology, indirectly competing with OncoSil Medical.

About

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe. Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Show more...
CEO
Mr. Nigel Lange
Country
Australia
ISIN
AU000000OSL3

Listings

STU
DE
N6A.STU
OTC Link
US
OCMLF
AU
AU
OSL.AU

0 Comments

Share your thoughts

FAQ

What is OncoSil Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange OncoSil Medical stocks are traded under the ticker N6A.STU.
When is the next OncoSil Medical earnings date?▼
OncoSil Medical is going to release the next earnings report on August 27, 2026.
What were OncoSil Medical earnings last quarter?▼
N6A.STU earnings for the last quarter are -0.71 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is OncoSil Medical revenue for the last year?▼
OncoSil Medical revenue for the last year amounts to 671,567.55 EUR.
What is OncoSil Medical net income for the last year?▼
N6A.STU net income for the last year is -8.69M EUR.
In which sector is OncoSil Medical located?▼
OncoSil Medical operates in the Other sector.
When did OncoSil Medical complete a stock split?▼
OncoSil Medical has not had any recent stock splits.
Where is OncoSil Medical headquartered?▼
OncoSil Medical is headquartered in Macquarie Park, Australia.